SmyleDC/pp65

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSmyleDC/pp65

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineCell and gene therapy > Cell therapy

Mechanisms of ActionT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMedizinische Hochschule Hannover

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMedizinische Hochschule Hannover

Active IndicationsN/A

Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A